Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR
Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
|6||Not yet recruiting||
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
† Indicates status has not been verified in more than two years